Adverse drug reactions associated with sunitinib therapy: Characteristics and risk factors

Adverse drug reactions associated with sunitinib therapy: Characteristics and risk factors

Background/Aim. Kidney tumors account for 2–3% of all tumors. Renal cell carcinoma (RCC) is the tenth most common malignancy. Sunitinib is used as the first treatment line in patients with a good and intermediate prognosis. The aim of this study was to analyze the risk factors, frequency, and advers...

Full description

Saved in:
Bibliographic Details
Main Authors: Mugoša Snežana, Džamić Zoran, Sahman-Zaimović Majda, Lukovac-Janjić Nevenka
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2021-01-01
Series:Vojnosanitetski Pregled
Subjects:
drug-related side effects and adverse reactions
kidney neoplasms
sunitinib
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84502000145M.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items